Iwatsubo K - Search Results

1

Central antinociceptive effect of L-ornithine, a metabolite of L-arginine, in rats and mice.

Kawabata A, Iwatsubo K, Takaya S, Takagi H. Kawabata A, et al. Among authors: iwatsubo k. Eur J Pharmacol. 1996 Jan 18;296(1):23-31. doi: 10.1016/0014-2999(95)00683-4. Eur J Pharmacol. 1996. PMID: 8720473

2

Characterization of beta-adrenergic receptor sequestration by newly developed whole cell binding assays.

Iwatsubo K, Tao Y, Onda T, Toya Y, Schwencke C, Fujita T, Ebina T, Iwamoto T, Hori H, Minamisawa S, Umemura S, Ishikawa Y. Iwatsubo K, et al. J Cardiovasc Pharmacol. 2003 Jan;41 Suppl 1:S53-6. J Cardiovasc Pharmacol. 2003. PMID: 12688397

3

Motor dysfunction in type 5 adenylyl cyclase-null mice.

Iwamoto T, Okumura S, Iwatsubo K, Kawabe J, Ohtsu K, Sakai I, Hashimoto Y, Izumitani A, Sango K, Ajiki K, Toya Y, Umemura S, Goshima Y, Arai N, Vatner SF, Ishikawa Y. Iwamoto T, et al. Among authors: iwatsubo k. J Biol Chem. 2003 May 9;278(19):16936-40. doi: 10.1074/jbc.C300075200. Epub 2003 Mar 28. J Biol Chem. 2003. PMID: 12665504 Free article.

4

Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration.

Iwatsubo K, Minamisawa S, Tsunematsu T, Nakagome M, Toya Y, Tomlinson JE, Umemura S, Scarborough RM, Levy DE, Ishikawa Y. Iwatsubo K, et al. J Biol Chem. 2004 Sep 24;279(39):40938-45. doi: 10.1074/jbc.M314238200. Epub 2004 Jul 15. J Biol Chem. 2004. PMID: 15262973 Free article.

5

Isoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapy.

Iwatsubo K, Tsunematsu T, Ishikawa Y. Iwatsubo K, et al. Expert Opin Ther Targets. 2003 Jun;7(3):441-51. doi: 10.1517/14728222.7.3.441. Expert Opin Ther Targets. 2003. PMID: 12783579 Review.

6

Disruption of type 5 adenylyl cyclase negates the developmental increase in Galphaolf expression in the striatum.

Iwamoto T, Iwatsubo K, Okumura S, Hashimoto Y, Tsunematsu T, Toya Y, Hervé D, Umemura S, Ishikawa Y. Iwamoto T, et al. Among authors: iwatsubo k. FEBS Lett. 2004 Apr 23;564(1-2):153-6. doi: 10.1016/S0014-5793(04)00333-3. FEBS Lett. 2004. PMID: 15094058 Free article.

7

Drug therapy aimed at adenylyl cyclase to regulate cyclic nucleotide signaling.

Iwatsubo K, Okumura S, Ishikawa Y. Iwatsubo K, et al. Endocr Metab Immune Disord Drug Targets. 2006 Sep;6(3):239-47. doi: 10.2174/187153006778249994. Endocr Metab Immune Disord Drug Targets. 2006. PMID: 17017975 Review.

8

Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress.

Okumura S, Vatner DE, Kurotani R, Bai Y, Gao S, Yuan Z, Iwatsubo K, Ulucan C, Kawabe J, Ghosh K, Vatner SF, Ishikawa Y. Okumura S, et al. Among authors: iwatsubo k. Circulation. 2007 Oct 16;116(16):1776-83. doi: 10.1161/CIRCULATIONAHA.107.698662. Epub 2007 Sep 24. Circulation. 2007. PMID: 17893275

9

Ischemic preconditioning prevents ischemia-induced beta-adrenergic receptor sequestration.

Iwatsubo K, Toya Y, Fujita T, Ebina T, Schwencke C, Minamisawa S, Umemura S, Ishikawa Y. Iwatsubo K, et al. J Mol Cell Cardiol. 2003 Aug;35(8):923-9. doi: 10.1016/s0022-2828(03)00173-1. J Mol Cell Cardiol. 2003. PMID: 12878479

10

Pharmacological stimulation of type 5 adenylyl cyclase stabilizes heart rate under both microgravity and hypergravity induced by parabolic flight.

Bai Y, Tsunematsu T, Jiao Q, Ohnuki Y, Mototani Y, Shiozawa K, Jin M, Cai W, Jin HL, Fujita T, Ichikawa Y, Suita K, Kurotani R, Yokoyama U, Sato M, Iwatsubo K, Ishikawa Y, Okumura S. Bai Y, et al. Among authors: iwatsubo k. J Pharmacol Sci. 2012;119(4):381-9. doi: 10.1254/jphs.12102fp. Epub 2012 Jul 31. J Pharmacol Sci. 2012. PMID: 22850613 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page